Main > ONCOLOGY (**) > MyeloFibrosis *** > Treatment > UK. G. JAK1/JAK2 & ACVR1 Inhibitor>

---

UK. G. JAK1/JAK2 & ACVR1 Inhibitor>'s subsections
(*) USA Approval Date: 2023. 09.15
(*) USA Launch Date: 2023. 09.25
>Oral
Company
Generic Name
TM
TM Web-Site
USA Patent Number

UK. G. JAK1/JAK2 & ACVR1 Inhibitor>'s products
This section has no products